← Evidence map

ArticlePloS one2020

Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy.

Anne-Sophie Hamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

56 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32579551